Pliant Therapeutics Inc.
PLRX | NASDAQ
$0.85
-$0.01 (-1.04%)
Nov 2, 2026, 10:39 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -22.37M | -20.04M | -23.58M | -26.3M | -43.3M | -56.17M | -49.73M | -57.76M | -55.85M | -46.96M | -41.11M | -41.49M | -41.19M | -37.55M | -35.06M | -30.62M | -29.55M | -28.1M | -24.53M | -27.05M | -22.83M | -22.86M |
Depreciation & Amortization | 249K | 264K | 365K | 436K | 447K | 448K | 458K | 532K | 622K | 513K | 464K | 448K | 477K | 452K | 455K | 454K | 459K | 455K | 418K | 388K | 370K | 359K |
Stock-Based Compensation | 4.19M | 4.25M | 4.53M | 6.42M | 6.38M | 8.91M | 8.42M | 8.9M | 10.64M | 9.67M | 9.15M | 10.36M | 13.05M | 11.92M | 10.86M | 4.81M | 3.4M | 3.53M | 2.77M | 2.81M | 2.28M | 2.58M |
Other Working Capital | 3.25M | -4.75M | -2.04M | -1.85M | -2.68M | -3.9M | -7.25M | 10.52M | 1.91M | 2.48M | -563K | -5.08M | 3.61M | -1.67M | -4.44M | 3.43M | 5.99M | 581K | -639K | 649K | 7K | -2.14M |
Other Non-Cash Items | 724K | 1.16M | 2.94M | 1.11M | 2.79M | 2.18M | 1.38M | 1.81M | 1M | 1.77M | 5.78M | 597K | 627K | -1.98M | -944K | -131K | 611K | 516K | 2.02M | 807K | 351K | 619K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.7M | -3.93M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 4.41M | -4.87M | -2.04M | -2.75M | -6.92M | -4.23M | -8.18M | 14.25M | -1.71M | 4.73M | 609K | -2.44M | 6.21M | -3.13M | -6.55M | 6.99M | 677K | 3.1M | -537K | 529K | 427K | 5.64M |
Operating Cash Flow | -12.8M | -19.23M | -17.79M | -21.08M | -40.6M | -48.86M | -47.66M | -32.27M | -45.3M | -30.27M | -25.1M | -36.22M | -24.76M | -30.28M | -31.24M | -18.5M | -24.4M | -20.5M | -19.87M | -22.51M | -19.4M | -13.67M |
Capital Expenditures | n/a | n/a | n/a | n/a | -112K | -262K | -209K | -896K | -1.25M | -1.49M | -61K | -94K | -603K | -163K | -166K | -696K | -254K | -644K | -592K | -480K | -639K | -242K |
Cash Acquisitions | 17K | 102K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -38.35M | 22.38M | n/a | n/a | 177.56M | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -17.32M | -64.9M | -85.09M | -52.56M | -51.61M | -14.15M | -33.36M | -77.03M | -48.52M | -52.38M | -57.5M | -114.48M | -134.48M | -276.62M | -36.31M | -211.35M | -38.82M | -39.23M | -37.92M | -43.14M | -74.03M | -64.81M |
Sales Maturities Of Investments | 32.79M | 60.7M | 86.85M | 80.33M | 87.21M | 83.53M | 72.7M | 108.89M | 60.48M | 113.41M | 89.48M | 152.82M | 112.1M | 102.58M | 56.5M | 33.8M | 45.57M | 41.4M | 64.3M | 75.72M | 78.25M | 77.28M |
Other Investing Acitivies | n/a | n/a | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 38.35M | -22.38M | n/a | n/a | -177.56M | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 15.49M | -4.1M | 1.77M | 27.92M | 35.49M | 69.11M | 39.13M | 30.96M | 10.7M | 59.55M | 31.92M | 38.25M | -22.98M | -174.21M | 20.02M | -178.25M | 6.5M | 1.53M | 25.78M | 32.1M | 3.58M | 12.23M |
Debt Repayment | n/a | n/a | -32.27M | n/a | n/a | n/a | 1K | n/a | n/a | 19.91M | n/a | n/a | n/a | n/a | -150K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.88M | n/a | 5M | -75K | -3.83M | 3.08M | 379K | -1.21M | 10.43M | -153K | -25K | -1.99M | 192K | 1.37M |
Financial Cash Flow | n/a | 74K | -32.27M | 72K | n/a | 498K | 102K | 543K | 684K | 21.79M | 219K | 699K | 161K | 273.33M | 284K | 216.3M | 10.43M | -153K | 516K | 449K | 192K | 1.37M |
Net Cash Flow | 2.69M | -23.26M | -48.29M | 6.91M | -5.12M | 20.75M | -8.43M | -770K | -33.91M | 51.06M | 5.56M | 2.73M | -47.58M | 68.84M | -10.93M | 19.55M | -7.48M | -19.12M | 6.43M | 10.04M | -15.63M | -63K |
Free Cash Flow | -12.8M | -19.23M | -17.79M | -21.08M | -40.72M | -49.13M | -47.87M | -33.17M | -46.55M | -31.76M | -25.16M | -36.32M | -25.36M | -30.44M | -31.41M | -19.19M | -24.65M | -21.14M | -20.46M | -22.99M | -20.04M | -13.91M |
Adj. Free Cash Flow | -16.98M | -23.48M | -22.31M | -27.5M | -47.09M | -58.04M | -56.29M | -42.07M | -57.19M | -41.43M | -34.32M | -46.68M | -38.41M | -42.36M | -42.26M | -24M | -28.05M | -24.67M | -23.23M | -25.8M | -22.32M | -16.49M |
Maintenance CapEx | n/a | n/a | n/a | n/a | -112K | -262K | -209K | -896K | -1.25M | -1.49M | -61K | -94K | -603K | -134.7K | -166K | -696K | n/a | -644K | -592K | -480K | -639K | -242K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -28.3K | n/a | n/a | -254K | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -12.8M | -19.23M | -17.79M | -21.08M | -40.72M | -49.13M | -47.87M | -33.17M | -46.55M | -31.76M | -25.16M | -36.32M | -25.36M | -30.41M | -31.41M | -19.19M | -24.4M | -21.14M | -20.46M | -22.99M | -20.04M | -13.91M |
Add to Watchlist
Select watchlists to add or remove PLRX